New patent for Astrazeneca drug LYNPARZA

Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eleven patents protecting…

Source


Comments are closed.

Biotechblog